2024 first quarter consolidated sales
2024/04/16 - Financial public releases
Focusing on animal health,
from the beginning
Virbac offers veterinarians, farmers and pet owners in more than 100 countries a comprehensive and practical range of products and services. With these innovative solutions covering the majority of animal species and diseases, Virbac contributes, day after day, to shape the future of animal health.
2024 first quarter consolidated sales
2024/04/16 - Financial public releases
Virbac acquired Sasaeah, a leading animal health player in Japan.
2024/04/02 - Financial public releases
On April 1, we successfully completed the acquisition of Sasaeah. This strategic acquisition brings Virbac a leadership position in the farm animal vaccines market in Japan, notably in the cattle segment, and a large portfolio of pharmaceutical products for all the major species.
Asia: our teams support growth in canine dermatology
2024/03/28 - Products
As in other parts of the world, around 10%1 of dogs in Asia suffer from atopic dermatitis. Since 2022, our teams have been stepping up their efforts to develop our global DailyDerma program in the region. The goal? To better help Asian veterinarians optimize their dermatology practices and improve the management of skin diseases, especially complex atopic dermatitis.